Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy

BACKGROUND: A proportion of patients develop recurrence following a tumour-negative sentinel lymph node biopsy (SLNB). This study aimed to explore whether melanoma patients with BRAF or NRAS mutant tumours have an increased risk of developing disease recurrence following a negative SLNB compared to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Cancer
Autors principals: Adler, Nikki R., Wolfe, Rory, McArthur, Grant A., Kelly, John W., Haydon, Andrew, McLean, Catriona A., Mar, Victoria J.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5959932/
https://ncbi.nlm.nih.gov/pubmed/29755118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0088-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars